Screener
Eligibility screening
ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
1 US site in IL
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.